ZA200604077B - Method of decreasing fat deposits and body weight in mammals and birds - Google Patents

Method of decreasing fat deposits and body weight in mammals and birds

Info

Publication number
ZA200604077B
ZA200604077B ZA2006/04077A ZA200604077A ZA200604077B ZA 200604077 B ZA200604077 B ZA 200604077B ZA 2006/04077 A ZA2006/04077 A ZA 2006/04077A ZA 200604077 A ZA200604077 A ZA 200604077A ZA 200604077 B ZA200604077 B ZA 200604077B
Authority
ZA
South Africa
Prior art keywords
birds
mammals
body weight
fat deposits
decreasing fat
Prior art date
Application number
ZA2006/04077A
Other languages
English (en)
Inventor
Gunnar A K Aberg
Original Assignee
Altergon Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altergon Pty Ltd filed Critical Altergon Pty Ltd
Publication of ZA200604077B publication Critical patent/ZA200604077B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
ZA2006/04077A 2003-11-20 2006-05-19 Method of decreasing fat deposits and body weight in mammals and birds ZA200604077B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52437603P 2003-11-20 2003-11-20
PCT/US2004/037966 WO2005051092A2 (en) 2003-11-20 2004-11-12 Method of decreasing fat deposits and body weight in mammals and birds
US10/987,665 US20050113456A1 (en) 2003-11-20 2004-11-12 Method of decreasing fat deposits and body weight in mammals and birds

Publications (1)

Publication Number Publication Date
ZA200604077B true ZA200604077B (en) 2009-11-29

Family

ID=34595131

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2006/04077A ZA200604077B (en) 2003-11-20 2006-05-19 Method of decreasing fat deposits and body weight in mammals and birds

Country Status (8)

Country Link
US (2) US20050113456A1 (enExample)
EP (1) EP1684593A4 (enExample)
JP (1) JP2007515402A (enExample)
AU (1) AU2004292416B2 (enExample)
CA (1) CA2545559A1 (enExample)
NZ (1) NZ547178A (enExample)
WO (1) WO2005051092A2 (enExample)
ZA (1) ZA200604077B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2384641T3 (es) 2005-07-14 2012-07-10 Lithera, Inc. Formulación lipolítica que potencia la liberación mantenida para el tratamiento localizado del tejido adiposo
US20070264313A1 (en) * 2006-05-12 2007-11-15 Musser Robert E Methods and compositions relating to animal dietary acids
AU2007313077B2 (en) * 2006-10-17 2011-06-02 Neothetics, Inc. Methods, compositions, and formulations for the treatment of thyroid eye disease
AU2008331928B2 (en) 2007-12-03 2012-08-16 Bridge Pharma, Inc. Use of RR/SR-ractopamine
MY159212A (en) 2008-09-02 2016-12-30 Nutricia Nv Nutritional compositions with coated lipid globules
WO2010068086A1 (en) 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
MX2012008171A (es) * 2010-01-15 2012-12-17 Lithera Inc Formulaciones aglomeradas liofilizadas.
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
EP2646012A4 (en) 2010-11-24 2014-12-10 Neothetics Inc MONOTHERAPEUTIC FORMULATIONS OF SELECTIVE, LIPOPHILIC AND PROLONGED BETA AGONISTS AND METHODS OF COSMETIC TREATMENT OF SILHOUETTE ADPOSITY AND REINFORCEMENT
BR112016009351B1 (pt) 2013-11-01 2020-12-22 N.V. Nutricia Uso de lipídio para a preparação de uma composição nutricional e fórmula para recémnascidos
KR102273533B1 (ko) * 2015-06-15 2021-07-06 삼성전자 주식회사 무선 통신 시스템에서 서비스 제공 방법 및 장치
PL3574771T3 (pl) 2015-10-15 2023-03-13 N.V. Nutricia Preparat do początkowego żywienia niemowląt mający specjalną architekturę lipidów do pobudzania zdrowego wzrostu
MY196605A (en) 2016-12-09 2023-04-20 Nutricia Nv Nutritional Composition for Improving Cell Membranes

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0085514A3 (en) * 1982-01-28 1984-02-29 Beecham Group Plc Compositions comprising a beta-antagonist and a beta-agonist, their preparation, and their use in treating obese humans and animals
GB8604134D0 (en) * 1986-02-19 1986-03-26 Glaxo Group Ltd Veterinary preparations
US5147869A (en) * 1986-12-11 1992-09-15 Roussel Uclaf Zootechnical compositions
IE60964B1 (en) * 1986-12-11 1994-09-07 Roussel Uclaf Zootechnical compositions containing a beta-adrenergic
US5541188A (en) * 1987-09-15 1996-07-30 The Rowett Research Institute Therapeutic applications of beta-adrenergic agonists
US5530029A (en) * 1987-09-15 1996-06-25 The Rowett Research Institute Therapeutic applications of clenbuterol
FR2642075B1 (fr) * 1989-01-25 1991-04-26 Pasteur Institut Polypeptides ayant une activite de recepteur (beta)-adrenergique chez l'homme, impliques dans la reponse lipolytique, acides nucleiques codant pour ces polypeptides et utilisation de ces polypeptides pour le criblage de substance active sur ces polypeptides
DK339289D0 (da) * 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
US5362755A (en) * 1990-01-05 1994-11-08 Sepracor, Inc. Method for treating asthma using optically pure (R)-albuterol
WO1991009596A1 (en) * 1990-01-05 1991-07-11 Sepracor, Inc. Optically pure r(-) albuterol for treating asthma
JP3358631B2 (ja) * 1993-05-17 2002-12-24 三菱瓦斯化学株式会社 メタノ−ルの脱水素方法
US5545745A (en) * 1994-05-23 1996-08-13 Sepracor, Inc. Enantioselective preparation of optically pure albuterol
US5399765A (en) * 1994-05-23 1995-03-21 Sepracor, Inc. Enantioselective preparation of optically pure albuterol
US5698199A (en) * 1995-03-10 1997-12-16 Kao Corporation Lipolysis acceleration method
US5708036A (en) * 1996-01-29 1998-01-13 Pesterfield, Jr.; E. Charles Method of treating premature uterine contractions using the optically active R(-)-isomer of albuterol
AU737608B2 (en) * 1997-04-30 2001-08-23 Courage Corporation Pty Ltd Composition and methods using an eutomer
US7767708B2 (en) * 1998-11-04 2010-08-03 Schering-Plough Animal Health Corp. Growth stimulant compositions
US6683115B2 (en) * 1999-06-02 2004-01-27 Theravance, Inc. β2-adrenergic receptor agonists
GB0030171D0 (en) * 2000-12-11 2001-01-24 Cipla Ltd Process for preparing isomers of salbutamol

Also Published As

Publication number Publication date
US20080020019A1 (en) 2008-01-24
US20050113456A1 (en) 2005-05-26
JP2007515402A (ja) 2007-06-14
NZ547178A (en) 2008-06-30
EP1684593A4 (en) 2010-02-10
AU2004292416B2 (en) 2010-01-28
WO2005051092A2 (en) 2005-06-09
WO2005051092A3 (en) 2006-04-06
CA2545559A1 (en) 2005-06-09
EP1684593A2 (en) 2006-08-02
AU2004292416A1 (en) 2005-06-09

Similar Documents

Publication Publication Date Title
IL175463A0 (en) Reduced fat flavored coating and methods of using same
EP1684593A4 (en) METHOD FOR REDUCING FAT DEPOSITS AND BODY WEIGHT IN MAMMALS AND BIRDS
SI1794174T1 (sl) Postopki in sestavki za inhibiranje prirojenih imunskih odzivov in avtoimunosti
EP1661025A4 (en) SYSTEMS AND METHOD FOR GENERATING AND USING AN ADAPTIVE REFERENCE MODEL
IL173967A0 (en) Lipid system and methods of use
ZA200600387B (en) Hydrolytically-resistant bornon-containing therapeutics and methods of use
EP1737519A4 (en) BODY PULSATION PROCESS AND DEVICE
EP1701654A4 (en) IMPLANTABLE BIOSPER AND METHODS OF USING SAME
EP1827362A4 (en) COMPOSITIONS AND METHODS OF USE FOR IMPROVING THE STATE AND THE APPEARANCE OF THE SKIN
IL183110A0 (en) Certain imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
IL218357A0 (en) Compositions and methods of using angiopoietin-like 4 protein
GB2389410B (en) Lighter and method of use
AU2003277259A8 (en) Immunoassay and method of use
AU2003299823A8 (en) Methods of inducing and maintaining immune tolerance
IL164647A0 (en) Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
EP1581095A4 (en) THERAPEUTIC METHODS FOR REDUCING FAT DEPOSIT AND TREATING THE DISEASES THEREOF
GB0517612D0 (en) Cooking apparatus and method of use
AU2003282755A8 (en) Methods of regulating body weight
AU2003216367A8 (en) Biglycan and related therapeutics and methods of use
GB0324523D0 (en) Compositions and methods of treatment
GB0302882D0 (en) Improvements in or relating to agents for the treatment of cardiovascular dysfunction and weight loss
EP1494750A4 (en) STIMULATION OF MUSCLES IN A IMMOBILIZED MEMBER IN A PLASTER
HK1087597A (en) Method of decreasing fat deposits and body weight in mammals and birds
EP1591008A4 (en) CANE BODY AND FISHING ROD
GB0415261D0 (en) Analog-to-digital interfacing device and method of analog-to-digital interfacing